OptimizeRx Corporation OPRX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 4.60M | 6.84M | 5.13M | 34.00K | -9.87M |
| Total Depreciation and Amortization | 4.45M | 4.46M | 4.49M | 4.50M | 4.50M |
| Total Amortization of Deferred Charges | 970.00K | 1.13M | 946.00K | 920.00K | 940.00K |
| Total Other Non-Cash Items | 8.32M | 7.60M | 7.33M | 8.02M | 16.15M |
| Change in Net Operating Assets | 92.00K | -5.64M | 816.00K | -1.64M | -1.31M |
| Cash from Operations | 18.43M | 14.38M | 18.72M | 11.83M | 10.41M |
| Capital Expenditure | -77.00K | -52.00K | -58.00K | -64.00K | -72.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 217.00K | 183.00K | 126.00K | -194.00K | -268.00K |
| Cash from Investing | 140.00K | 131.00K | 68.00K | -258.00K | -340.00K |
| Total Debt Issued | 24.30M | -- | -- | -- | -- |
| Total Debt Repaid | -34.60M | -10.19M | -8.00M | -8.00M | -8.00M |
| Issuance of Common Stock | 352.00K | 352.00K | 352.00K | 338.00K | -- |
| Repurchase of Common Stock | -1.12M | -1.08M | -1.15M | -512.00K | -448.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -11.07M | -10.92M | -8.80M | -8.17M | -8.45M |
| Foreign Exchange rate Adjustments | 11.00K | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.51M | 3.60M | 9.99M | 3.39M | 1.63M |